Replies to post #2953 on Synergy Pharmaceuticals Inc fka SGYPQ

[iandy]

>Moving forward, direct-to-consumer advertising could yield a “meaningful positive impact” next year in bolstering awareness of Trulance, which could help the biotech player “level the competition field to some extent.” <

I know I sound like a broken record but it’s really crazy the company didn’t mention DTC plans at all. They didn’t even respond when asked about it.
They at least mentioned it as a possibility down the road on the last call.
I’m really frustrated with the company and the stock.
I know they want to wait till the right time and it’s on more formularies but I’m not patient.
They are burning a lot of cash and haven’t even started DTC which is what made Linzess sales take off.

The freekin chart resembles a bowel movement.